Home NDC 50090-5593 Acetazolamide
Product NDC 50090-5593
11-digit product format 500905593
Labeler code 50090
Product ID 50090-5593_3486ecfd-aedf-47bf-b0e6-0305b3965c82
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Acetazolamide
Dosage form TABLET
Route ORAL
Labeler A-S Medication Solutions
Application ANDA209734
Marketing category ANDA
Marketing start 2017-11-20
Substance ACETAZOLAMIDE
Active strength 250 mg/1
Pharmacologic classes Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A209734-001 ACETAZOLAMIDE ACETAZOLAMIDE 125MG TABLET / ORAL AB 2017-11-20 A209734-002 ACETAZOLAMIDE ACETAZOLAMIDE 250MG TABLET / ORAL AB 2017-11-20
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A209734-001 ACETAZOLAMIDE 125MG TABLET / ORAL AB 2017-11-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A209734-002 ACETAZOLAMIDE 250MG TABLET / ORAL AB 2017-11-20 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A209734-001 ACETAZOLAMIDE 125MG TABLET / ORAL AB 2017-11-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A209734-002 ACETAZOLAMIDE 250MG TABLET / ORAL AB 2017-11-20 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A209734-001 ACETAZOLAMIDE 125MG TABLET / ORAL AB 2017-11-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A209734-002 ACETAZOLAMIDE 250MG TABLET / ORAL AB 2017-11-20 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A209734-001 ACETAZOLAMIDE 125MG TABLET / ORAL AB 2017-11-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A209734-002 ACETAZOLAMIDE 250MG TABLET / ORAL AB 2017-11-20 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A209734-001 ACETAZOLAMIDE 125MG TABLET / ORAL AB 2017-11-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A209734-002 ACETAZOLAMIDE 250MG TABLET / ORAL AB 2017-11-20 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A209734-001 ACETAZOLAMIDE 125MG TABLET / ORAL AB 2017-11-20 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A209734-002 ACETAZOLAMIDE 250MG TABLET / ORAL AB 2017-11-20 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A209734-001 ACETAZOLAMIDE 125MG TABLET / ORAL AB 2017-11-20 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A209734-002 ACETAZOLAMIDE 250MG TABLET / ORAL AB 2017-11-20 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A209734-001 ACETAZOLAMIDE 125MG TABLET / ORAL AB 2017-11-20 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A209734-002 ACETAZOLAMIDE 250MG TABLET / ORAL AB 2017-11-20 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A209734-001 ACETAZOLAMIDE 125MG TABLET / ORAL AB 2017-11-20 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A209734-002 ACETAZOLAMIDE 250MG TABLET / ORAL AB 2017-11-20 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A209734-001 ACETAZOLAMIDE 125MG TABLET / ORAL AB 2017-11-20 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A209734-002 ACETAZOLAMIDE 250MG TABLET / ORAL AB 2017-11-20 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A209734-001 ACETAZOLAMIDE 125MG TABLET / ORAL AB 2017-11-20 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A209734-002 ACETAZOLAMIDE 250MG TABLET / ORAL AB 2017-11-20 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A209734-001 ACETAZOLAMIDE 125MG TABLET / ORAL AB 2017-11-20 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A209734-002 ACETAZOLAMIDE 250MG TABLET / ORAL AB 2017-11-20 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A209734-001 ACETAZOLAMIDE 125MG TABLET / ORAL AB 2017-11-20 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A209734-002 ACETAZOLAMIDE 250MG TABLET / ORAL AB 2017-11-20 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A209734-001 ACETAZOLAMIDE 125MG TABLET / ORAL AB 2017-11-20 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A209734-002 ACETAZOLAMIDE 250MG TABLET / ORAL AB 2017-11-20 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A209734-001 ACETAZOLAMIDE 125MG TABLET / ORAL AB 2017-11-20 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A209734-002 ACETAZOLAMIDE 250MG TABLET / ORAL AB 2017-11-20 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A209734-001 ACETAZOLAMIDE 125MG TABLET / ORAL AB 2017-11-20 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A209734-002 ACETAZOLAMIDE 250MG TABLET / ORAL AB 2017-11-20 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A209734-001 ACETAZOLAMIDE 125MG TABLET / ORAL AB 2017-11-20 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A209734-002 ACETAZOLAMIDE 250MG TABLET / ORAL AB 2017-11-20 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A209734-001 ACETAZOLAMIDE 125MG TABLET / ORAL AB 2017-11-20 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A209734-002 ACETAZOLAMIDE 250MG TABLET / ORAL AB 2017-11-20 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A209734-001 ACETAZOLAMIDE 125MG TABLET / ORAL AB 2017-11-20 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A209734-002 ACETAZOLAMIDE 250MG TABLET / ORAL AB 2017-11-20 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A209734-001 ACETAZOLAMIDE 125MG TABLET / ORAL AB 2017-11-20 782e0a99824c…2021-12-28 21:50 UTC 2021-12 A209734-002 ACETAZOLAMIDE 250MG TABLET / ORAL AB 2017-11-20 782e0a99824c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 82 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Acetazolamide
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ACETAZOLAMIDE 250 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination O3FX965V0I Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 197304 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 50090-5593-0 Acetazolamide 12 in 1 BOTTLE TABLET 12 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 50090-5593 ACETAZOLAMIDE TABLET [A-S MEDICATION SOLUTIONS] 5 Current NDC, Legacy NDC, 1 package rows 20240606_e9152bc5-5817-4a6a-9d2a-0dd77074f501.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 6 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Acetazolamide ACETAZOLAMIDE PD-Rx Pharmaceuticals, Inc. 268db224-d5db-457c-86bc-972c9fe07917 2026-07-07 Warnings, Adverse reactions Exact identifier application applno (ANDA): 209734 application number: ANDA209734 Acetazolamide ACETAZOLAMIDE Strides Pharma Science Limited 4813b9dd-5f58-44bb-ad64-cdb331828080 2026-07-01 Warnings, Adverse reactions Exact identifier application applno (ANDA): 209734 application number: ANDA209734 Acetazolamide ACETAZOLAMIDE AvPAK a9dca448-5511-413e-e053-2a95a90a8c66 2026-01-08 Warnings, Adverse reactions Exact identifier application applno (ANDA): 209734 application number: ANDA209734 Acetazolamide ACETAZOLAMIDE NuCare Pharmaceuticlas, Inc. 278878bc-da9c-09d4-e063-6394a90abaf7 2024-11-22 Warnings, Adverse reactions Exact identifier application applno (ANDA): 209734 application number: ANDA209734 Acetazolamide ACETAZOLAMIDE A-S Medication Solutions e9152bc5-5817-4a6a-9d2a-0dd77074f501 2024-06-05 Warnings, Adverse reactions Exact identifier application applno (ANDA): 209734 application number: ANDA209734 ndc (product): 50090-5593 Acetazolamide ACETAZOLAMIDE Proficient Rx LP 3cdde6aa-c89d-4ea4-aade-6c8b5c3ffdcc 2019-10-01 Warnings, Adverse reactions Exact identifier application applno (ANDA): 209734 application number: ANDA209734
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 50090-5593-0 50090559300 12 TABLET in 1 BOTTLE (50090-5593-0) 12 tablet 2021-07-16 0000-00-00 No No Current